Yaming Li
Papers
2
Total Citations
32
H-Index
2
About
Dr. Yaming Li is a leading surgical oncologist whose research focuses on advancing minimally invasive hepatopancreatobiliary surgery, particularly through the adoption and optimization of robotic techniques. Dr. Li’s major contributions center on systematically addressing the steep learning curve associated with complex robotic procedures, such as the pancreaticoduodenectomy. Their landmark 2021 study, cited 18 times, established a comprehensive training protocol that demonstrably mitigates operative risks and improves patient outcomes during the adoption phase of robotic surgery. Further demonstrating their impact, Dr. Li led a pivotal national cohort study (2022, 14 citations) comparing robotic and open resection for intrahepatic cholangiocarcinoma, providing critical evidence that robotic approaches can achieve comparable short- and long-term oncologic outcomes while offering the benefits of minimally invasive surgery. This work has helped define best practices for surgeons transitioning to robotic platforms. By providing rigorous, evidence-based frameworks for training and outcomes assessment, Dr. Li is shaping the future of surgical oncology, making advanced robotic procedures safer and more accessible for patients with complex liver and pancreatic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2